Record Revenue and Adjusted EBITDA
Full-year 2025 revenue of $270.3M, up ~21% YoY; Q4 revenue $76.2M, up 26% YoY. Record adjusted EBITDA of $61.4M for 2025 with a margin of ~22.7%; Q4 adjusted EBITDA of $18.2M.
Strong Free Cash Flow and Cash Generation
Net cash provided by operating activities of $51.9M in 2025. Free cash flow totaled $28.1M (vs $11.6M in 2024), more than doubling year over year; Q4 free cash flow $10.8M. Net cash of $13.5M and $46M available under credit facilities with long-term debt of $11.3M (effectively no net debt).
Rapid Growth in Sleep and Resupply
PATH therapy patient count reached 34,528 as of 12/31/2025, +62% YoY. New sleep patient setups increased 70% in 2025. Resupply patients totaled 36,561, up 49% YoY. Sleep increased from 16% to 20% of revenue year-over-year.
Diversification of Revenue Mix
Ventilation contribution declined from 56% to 51% of revenue as other categories scaled. Equipment and supply sales increased ~$19.4M (~63% YoY). Ventilator rentals increased ~$12.2M (~10% YoY). Other non-vent HME rentals +$9.7M (~20% YoY); services revenue +$4.8M (~24% YoY). Maternal health contributed ~3% of 2025 revenue (~$9.0M).
Accretive Acquisition and New Growth Engine
Lehan’s Medical Equipment acquisition (closed July 1) integrated smoothly and was accretive immediately, producing positive net income contribution in both quarters post-close. Maternal health generated ~$9M of revenue in 2025 and is positioned for scalable expansion.
Operational and Regulatory Strength
Company reports strong compliance/documentation capabilities: 100% success rate at the ALJ level on appealed Medicare Advantage denials under the new NCD and earlier resolution of denials. January 2026 was one of the strongest months for new ventilator setups in company history.
Prudent Capital Allocation
Board authorized a new share repurchase program for 2026 after buying back 5% of outstanding shares at an average price of $6.69 in 2025. Guidance for 2026: revenue $310M–$320M (midpoint ~17% YoY) and adjusted EBITDA $65M–$69M.